{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:43:22Z","timestamp":1790707402169,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002660","name":"Islamic Azad University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.intimp.2024.112204","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T18:55:04Z","timestamp":1714762504000},"page":"112204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["A novel vaccine strategy against Brucellosis using Brucella abortus multi-epitope OMPs vaccine based on Lactococcus lactis live bacterial vectors"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0041-5842","authenticated-orcid":false,"given":"Tohid","family":"Piri-Gharaghie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazal","family":"Ghajari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnoosh","family":"Rezaeizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohaned","family":"Adil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed H.","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2024.112204_b0005","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3390\/microorganisms10050942","article-title":"Facing the human and animal brucellosis conundrums: the forgotten lessons","volume":"10","author":"Moreno","year":"2022","journal-title":"Microorganisms"},{"issue":"11","key":"10.1016\/j.intimp.2024.112204_b0010","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.3390\/ijms23116131","article-title":"Generation and selection of specific aptamers targeting Brucella species through an enhanced cell-SELEX methodology","volume":"23","author":"El-Husseini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112204_b0015","doi-asserted-by":"crossref","first-page":"1157211","DOI":"10.3389\/fvets.2023.1157211","article-title":"Serological and molecular prevalence of Brucella spp. among livestock species in Rajasthan, India","volume":"10","author":"Meena","year":"2023","journal-title":"Front. Veterinary Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.112204_b0020","first-page":"337","article-title":"Brucellosis: current status of the disease and future perspectives","volume":"59","author":"Sulayman","year":"2020","journal-title":"Post\u0119py Mikrobiologii-Adv. Microbiol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112204_b0025","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/pathogens12121450","article-title":"Immune responses potentially involved in the gestational complications of Brucella infection","volume":"12","author":"Zavattieri","year":"2023","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.intimp.2024.112204_b0030","first-page":"118","article-title":"Human and animal brucellosis: a comprehensive review of biology, pathogenesis, epidemiology, risk factors, clinical signs, laboratory diagnosis","volume":"8","author":"Pal","year":"2020","journal-title":"Am. J. Infect. Dis."},{"key":"10.1016\/j.intimp.2024.112204_b0035","doi-asserted-by":"crossref","first-page":"01","DOI":"10.62310\/liab.v4i1.128","article-title":"A systematic overview of bovine brucellosis and its implications for public health: Bovine Brucellosis: A Zoonotic Threat","author":"Idrees","year":"2024","journal-title":"Lett. Anim. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112204_b0040","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4049\/jimmunol.2200642","article-title":"Bacillus Calmette-Gu\u00e9rin\u2013trained macrophages elicit a protective inflammatory response against the pathogenic bacteria Brucella abortus","volume":"211","author":"de Araujo","year":"2023","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112204_b0045","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3109\/1040841X.2014.972335","article-title":"Effects of climate change on the persistence and dispersal of foodborne bacterial pathogens in the outdoor environment: A review","volume":"42","author":"Hellberg","year":"2016","journal-title":"Crit. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112204_b0050","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/vaccines11030654","article-title":"The development of diagnostic and vaccine strategies for early detection and control of human brucellosis, particularly in endemic areas","volume":"11","author":"Elbehiry","year":"2023","journal-title":"Vaccines"},{"issue":"7","key":"10.1016\/j.intimp.2024.112204_b0055","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4236\/aim.2022.127030","article-title":"A review on brucellosis in Cameroon: diagnostic approaches, epidemiology and risk factors for infection","volume":"12","author":"Eko","year":"2022","journal-title":"Adv. Microbiol."},{"key":"10.1016\/j.intimp.2024.112204_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115875","article-title":"Nano and microparticle drug delivery systems for the treatment of Brucella infections","volume":"169","author":"Razei","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.112204_b0065","unstructured":"Piri Gharaghie, Tohid, Sameh Hajimohammadi, Comparison of anti-candida effects of aqueous, ethanolic extracts and essential oil of E. angustifolia with fluconazole on the growth of clinical strains of Candida, New Cell. Mol. Biotechnol. J. 11.43 (2021): 25-38."},{"key":"10.1016\/j.intimp.2024.112204_b0070","doi-asserted-by":"crossref","first-page":"1255239","DOI":"10.3389\/fvets.2023.1255239","article-title":"Brucellae as resilient intracellular pathogens: epidemiology, host\u2013pathogen interaction, recent genomics and proteomics approaches, and future perspectives","volume":"10","author":"Dawood","year":"2023","journal-title":"Front. Veterinary Sci."},{"issue":"01","key":"10.1016\/j.intimp.2024.112204_b0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40249-021-00801-y","article-title":"A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model","volume":"10","author":"Bugybayeva","year":"2021","journal-title":"Infect. Dis. Poverty"},{"issue":"10","key":"10.1016\/j.intimp.2024.112204_b0080","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/rheumatology\/keq183","article-title":"Vaccinations in patients with immune-mediated inflammatory diseases","volume":"49","author":"Rahier","year":"2010","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.intimp.2024.112204_b0085","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1128\/IAI.73.6.3294-3300.2005","article-title":"An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu, Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB\/c mice","volume":"73","author":"Onate","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2024.112204_b0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fcimb.2013.00017","article-title":"Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis","volume":"3","author":"Gomez","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112204_b0095","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11274-023-03771-5","article-title":"Lactococcus lactis, a bacterium with probiotic functions and pathogenicity","volume":"39","author":"Wu","year":"2023","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112204_b0100","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/vms3.1173","article-title":"Brucella abortus antigen omp25 vaccines: development and targeting based on Lactococcus lactis","volume":"9","author":"Gouran","year":"2023","journal-title":"Veterinary Med. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.112204_b0105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00203-023-03471-6","article-title":"Oral vaccination with novel Lactococcus lactis mucosal live vector-secreting Brucella lumazine synthase (BLS) protein induces humoral and cellular immune protection against Brucella abortus","volume":"205","author":"Fatehi","year":"2023","journal-title":"Arch. Microbiol."},{"issue":"25","key":"10.1016\/j.intimp.2024.112204_b0110","first-page":"4957","article-title":"Kappa-casein gene polymorphism in Holstein and Iranian native cattle by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP)","volume":"10","author":"Doosti","year":"2011","journal-title":"Afr. J. Biotechnol."},{"issue":"8","key":"10.1016\/j.intimp.2024.112204_b0115","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1080\/07391102.2020.1756411","article-title":"Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study","volume":"39","author":"Enayatkhani","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.intimp.2024.112204_b0120","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1017\/S0950268821001229","article-title":"Design of a new multi-epitope vaccine against Brucella based on T and B cell epitopes using bioinformatics methods","volume":"149","author":"Chen","year":"2021","journal-title":"Epidemiol. Infect."},{"issue":"10","key":"10.1016\/j.intimp.2024.112204_b0125","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1007\/s12010-022-03995-5","article-title":"Identification of antigenic properties of Acinetobacter baumannii proteins as novel putative vaccine candidates using reverse vaccinology approach","volume":"194","author":"Piri-Gharaghie","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.intimp.2024.112204_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.07.002","article-title":"A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation","volume":"473","author":"Fischinger","year":"2019","journal-title":"J. Immunol. Methods"},{"issue":"5","key":"10.1016\/j.intimp.2024.112204_b0135","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012476","article-title":"Vaccines, reverse vaccinology, and bacterial pathogenesis","volume":"3","author":"Delany","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112204_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/002367767781006839","article-title":"The establishment of a specific-pathogen-free (SPF) rat and mouse breeding unit","volume":"1","author":"Walker","year":"1967","journal-title":"Lab. Anim"},{"issue":"1","key":"10.1016\/j.intimp.2024.112204_b0145","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.1093\/ilar.53.1.55","article-title":"Mice anesthesia, analgesia, and care, Part I: anesthetic considerations in preclinical research","volume":"53","author":"Gargiulo","year":"2012","journal-title":"ILAR J."},{"issue":"7","key":"10.1016\/j.intimp.2024.112204_b0150","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/vaccines9070770","article-title":"A quantitative ELISA protocol for detection of specific human IgG against the SARS-CoV-2 spike protein","volume":"9","author":"Vernet","year":"2021","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.intimp.2024.112204_b0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13568-023-01531-0","article-title":"Novel adjuvant nano-vaccine induced immune response against Acinetobacter baumannii","volume":"13","author":"Piri-Gharaghie","year":"2023","journal-title":"AMB Express"},{"issue":"2","key":"10.1016\/j.intimp.2024.112204_b0160","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0976-500X.72351","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"1","author":"Kilkenny","year":"2010","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"2","key":"10.1016\/j.intimp.2024.112204_b0165","first-page":"231","article-title":"Recent advances in vaccine technologies","volume":"48","author":"Francis","year":"2018","journal-title":"Veterinary Clin.: Small Animal Practice"},{"issue":"2","key":"10.1016\/j.intimp.2024.112204_b0170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/cei.13287","article-title":"Novel approaches for the design, delivery and administration of vaccine technologies","volume":"196","author":"Wallis","year":"2019","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112204_b0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13567-021-00939-5","article-title":"Screening of potential vaccine candidates against pathogenic Brucella spp. using compositive reverse vaccinology","volume":"52","author":"Zai","year":"2021","journal-title":"Vet. Res."},{"issue":"2","key":"10.1016\/j.intimp.2024.112204_b0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/medsci6020027","article-title":"Live bacterial vectors\u2014a promising DNA vaccine delivery system","volume":"6","author":"Yurina","year":"2018","journal-title":"Medical Sciences"},{"key":"10.1016\/j.intimp.2024.112204_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2020.101470","article-title":"High protection of mice against Brucella abortus by oral immunization with recombinant probiotic Lactobacillus casei vector vaccine, expressing the outer membrane protein OMP19 of Brucella species","volume":"70","author":"Mohammadi","year":"2020","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.112204_b0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/IAI.00952-06","article-title":"A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice","volume":"75","author":"Delpino","year":"2007","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.intimp.2024.112204_b0195","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection","volume":"77","author":"Pasquevich","year":"2009","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.intimp.2024.112204_b0200","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.4049\/jimmunol.0902209","volume":"184","author":"Pasquevich","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112204_b0205","doi-asserted-by":"crossref","first-page":"e16203","DOI":"10.1371\/journal.pone.0016203","article-title":"An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice","volume":"6","author":"Pasquevich","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112204_b0210","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1590\/S1517-83822014000400001","article-title":"Live bacterial vaccine vectors: an overview","volume":"45","author":"Silva","year":"2014","journal-title":"Braz. J. Microbiol."},{"issue":"13-14","key":"10.1016\/j.intimp.2024.112204_b0215","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0264-410X(00)00354-6","article-title":"Use of live bacterial vaccine vectors for antigen delivery: potential and limitations","volume":"19","author":"Medina","year":"2001","journal-title":"Vaccine"},{"issue":"7-8","key":"10.1016\/j.intimp.2024.112204_b0220","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0264-410X(02)00603-5","article-title":"Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives","volume":"21","author":"Sala","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.intimp.2024.112204_b0225","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imm.13526","article-title":"Vaccines, adjuvants and key factors for mucosal immune response","volume":"167","author":"Correa","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2024.112204_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.589234","article-title":"The outer membrane proteins OmpA, CarO, and OprD of Acinetobacter baumannii confer a two-pronged defense in facilitating its success as a potent human pathogen","volume":"11","author":"Uppalapati","year":"2020","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112204_b0235","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/proteomes8020008","article-title":"Proteomics of Brucella","volume":"8","author":"Poetsch","year":"2020","journal-title":"Proteomes"},{"issue":"16","key":"10.1016\/j.intimp.2024.112204_b0240","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.vaccine.2015.02.061","article-title":"Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization","volume":"33","author":"Li","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.intimp.2024.112204_b0245","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/713608012","article-title":"T cell immunity to brucellosis","volume":"29","author":"Yingst","year":"2003","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.intimp.2024.112204_b0250","first-page":"5","article-title":"Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection?","volume":"26","author":"Baldwin","year":"2006","journal-title":"Crit. Rev.\u2122 Immunol."},{"key":"10.1016\/j.intimp.2024.112204_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.616713","article-title":"Modulatory effects of probiotics during pathogenic infections with emphasis on immune regulation","volume":"12","author":"Raheem","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2024.112204_b0260","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3390\/microorganisms10071260","article-title":"Immunosuppressive mechanisms in brucellosis in light of chronic bacterial diseases","volume":"10","author":"Pellegrini","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.intimp.2024.112204_b0265","doi-asserted-by":"crossref","first-page":"30398","DOI":"10.3389\/fimmu.2012.00275","article-title":"Transcriptional regulation of the anti-inflammatory cytokine IL-10 in acquired immune cells","volume":"3","author":"Kubo","year":"2012","journal-title":"Front. Immunol."}],"updated-by":[{"DOI":"10.1016\/j.intimp.2025.115559","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924007227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924007227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T09:04:09Z","timestamp":1735290249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924007227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":53,"alternative-id":["S1567576924007227"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112204","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel vaccine strategy against Brucellosis using Brucella abortus multi-epitope OMPs vaccine based on Lactococcus lactis live bacterial vectors","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112204"}}